Fabio Baschiera

Company: Bayer

Job title: Global Clinical Leader, Ophthalmology

Seminars:

Panel Discussion: How Can We Practically Implement New Treatments for Retinal Vascular Disorders, Streamlining Clinical Trials to Set Yourself Up for Success? 12:00 pm

How can you streamline trial design, incorporating new drug and technology advancements, to ensure a smoother transition through clinical phases for retinal therapies? What are the best strategies for forming partnerships and collaborations to support clinical development and commercialization efforts? How can patient engagement and feedback be integrated into the development process to enhance the…Read more

day: Day One

Activating Soluble Guanylate Cyclase for Non-Proliferative Diabetic Retinopathy (NPDR) Treatment 2:30 pm

Presenting preclinical data on runcaciguat’s ability to activate soluble guanylate cyclase, aiming to improve retinal blood flow and reduce inflammation in NPDR Designing the Phase 2 NEON-NPDR trial to demonstrate how runcaciguat’s preclinical efficacy translates into clinical benefits for patients with NPDR Reflecting on current trial results that indicate potential improvements in retinal health and…Read more

day: Day One